Aptorum Group Ltd - Ordinary Shares - Class A

NASDAQ:APM   9:40:30 AM EDT
2.69
+0.03 (+1.13%)
Products

Aptorum Group Limited Receives IND Clearance From U.S. FDA to Initiate Clinical Trials for Treatment of Neuroblastoma

Published: 09/15/2021 12:13 GMT
Aptorum Group Ltd - Ordinary Shares - Class A (APM) - Aptorum Group Limited Has Received Ind Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug Sact-1 for the Treatment of Neuroblastoma.